Denali Therapeutics Inc (BSP:D2NL34)
R$ 27.06 (0%) Market Cap: 20.67 Bil Enterprise Value: 17.15 Bil PE Ratio: 0 PB Ratio: 4.91 GF Score: 6/100

Denali Therapeutics Inc (BSP:D2NL34) Transcripts

  • 1